sharesgurusharesguru
  • Stocks
  • Ai Screener
  • Sectors
  • Watchlist
LoginSign Up
sharesguru
  • Home
  • Stocks
  • Ai Screener
  • Sectors
  • Watchlist
  • Profile
  • Contact Us
LoginSign Up
sharesguru

Discover the joy of investing.

All the financial data and tools you need, at one place.

Navigation

  • Home
  • Stocks
  • Sectors

Tools

  • Ai Screener
  • Watchlists

Company

  • Contact

Legal

  • Privacy Policy
  • Terms of Service
Copyright © 2025 Knowtilus Technologies Pvt. Ltd.
SummaryLatest NewsSector ComparisonEarnings ReportRevenue & GrowthPeersIncome StatementBalance SheetCash Flow
NATHBIOGEN logo

NATHBIOGEN - Nath Biogene India Ltd. Share Price

Agricultural Food & otherProducts

₹152.33+2.89(+1.93%)
Market Closed as of Feb 6, 2026, 15:30 IST

Valuation

Market Cap283.9 Cr
Price/Earnings (Trailing)6.61
Price/Sales (Trailing)0.62
EV/EBITDA6.74
Price/Free Cashflow33.34
MarketCap/EBT5.92
Enterprise Value437.99 Cr

Fundamentals

Growth & Returns

Price Change 1W4%
Price Change 1M-4.9%
Price Change 6M-19%
Price Change 1Y-10.9%
3Y Cumulative Return-1.5%
5Y Cumulative Return-11.3%
7Y Cumulative Return-12.6%
10Y Cumulative Return6.2%
Revenue (TTM)
454.77 Cr
Rev. Growth (Yr)81.2%
Earnings (TTM)43.12 Cr
Earnings Growth (Yr)-39.4%

Profitability

Operating Margin9%
EBT Margin11%
Return on Equity6.34%
Return on Assets4.25%
Free Cashflow Yield3%

Cash Flow & Liquidity

Cash Flow from Investing (TTM)-3.96 Cr
Cash Flow from Operations (TTM)17.58 Cr
Cash Flow from Financing (TTM)-2.13 Cr
Cash & Equivalents74.24 L
Free Cash Flow (TTM)9.66 Cr
Free Cash Flow/Share (TTM)5.08

Balance Sheet

Total Assets1.01 kCr
Total Liabilities334.32 Cr
Shareholder Equity679.85 Cr
Current Assets706.39 Cr
Current Liabilities316.61 Cr
Net PPE243.08 Cr
Inventory307.96 Cr
Goodwill0.00

Capital Structure & Leverage

Debt Ratio0.15
Debt/Equity0.23
Interest Coverage2.76
Interest/Cashflow Ops2.66

Dividend & Shareholder Returns

Dividend/Share (TTM)2
Dividend Yield1.34%
Shares Dilution (1Y)0.00%
Shares Dilution (3Y)0.00%
Pros

Growth: Good revenue growth. With 48.6% growth over past three years, the company is going strong.

Profitability: Recent profitability of 9% is a good sign.

Technicals: Bullish SharesGuru indicator.

Balance Sheet: Strong Balance Sheet.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Cons

Size: It is a small market cap company and can be volatile.

Past Returns: Underperforming stock! In past three years, the stock has provided -1.5% return compared to 13% by NIFTY 50.

Smart Money: Smart money looks to be reducing their stake in the stock.

Price to Sales Ratio

Latest reported: 0.6

Revenue (Last 12 mths)

Latest reported: 454.8 Cr

Net Income (Last 12 mths)

Latest reported: 43.1 Cr
Pros

Growth: Good revenue growth. With 48.6% growth over past three years, the company is going strong.

Profitability: Recent profitability of 9% is a good sign.

Technicals: Bullish SharesGuru indicator.

Balance Sheet: Strong Balance Sheet.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Cons

Size: It is a small market cap company and can be volatile.

Past Returns: Underperforming stock! In past three years, the stock has provided -1.5% return compared to 13% by NIFTY 50.

Smart Money: Smart money looks to be reducing their stake in the stock.

Investor Care

Dividend Yield1.34%
Dividend/Share (TTM)2
Shares Dilution (1Y)0.00%
Earnings/Share (TTM)22.61

Financial Health

Current Ratio2.23
Debt/Equity0.23

Technical Indicators

RSI (14d)52.98
RSI (5d)76.92
RSI (21d)44.08
MACD SignalBuy
Stochastic Oscillator SignalHold
SharesGuru SignalBuy
RSI SignalHold
RSI5 SignalSell
RSI21 SignalHold
SMA 5 SignalBuy
SMA 10 Signal

Summary of Latest Earnings Report from Nath Biogene India

Summary of Nath Biogene India's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

Management's outlook for Nath Bio-Genes (India) Limited emphasizes resilience in the face of climate unpredictability, marking the first half of fiscal year 2026 as a testing period. The company reported a steady operational performance despite challenges, particularly in the cotton segment which saw a volume growth of 6% year-on-year, reaching 1.11 million packets, and a substantial value growth of 26.3%. The paddy segment also demonstrated nominal volume growth with a significant 10% in value, while maize recorded a sharp 17.3% recovery.

Management pointed out that illegal BT cotton and RRF cotton continue to pose challenges but expressed hope for industry regularization to protect farmers and ensure fair competition. The vegetable seeds segment emerged as the fastest-growing area, with a robust 25% year-on-year value growth.

Looking forward, management outlined key ambitions including:

  • Accelerating diversification beyond cotton.
  • Maintaining an overall revenue growth target of around 15% for the current fiscal year and 15-20% for FY27.
  • Advancing R&D initiatives to enhance product offerings and market resilience.

On the financial side, half-year revenue reached INR 3,199 million, reflecting a year-on-year growth of 15.9%, with gross profit increasing by 21.3%. EBITDA and PAT saw increases of 5.7% and 15.3%, respectively, reaching INR 424 million.

The primary focus remains on delivering superior, resilient products to bolster farmer trust amid changing climatic conditions, creating value for stakeholders in the years to come.

Share Holdings

Understand Nath Biogene India ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Share Holding Details

Shareholder NameHolding %
ASHU FARMS LLP13.68%
AKASH FARMS LLP12.24%
MAYO FARMS LLP5.72%
TAPOVAN FARMS LLP5.18%
EMERALD SEEDS PRIVATE LIMITED3.63%
TINGLI FINVEST PVT LTD2.96%
NATH INDUSTRIES LIMITED2.8%

Is Nath Biogene India Better than it's peers?

Detailed comparison of Nath Biogene India against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker
Name
Mkt Cap
Revenue
Price %, 1M
Returns, 1Y
P/E
P/S
Rev 1-Yr
Inc 1-Yr
---------

Sector Comparison: NATHBIOGEN vs Agricultural Food & otherProducts

Comprehensive comparison against sector averages

Comparative Metrics

NATHBIOGEN metrics compared to Agricultural

CategoryNATHBIOGENAgricultural
PE 6.6117.67
PS0.621.20
Growth27.4 %12.3 %
0% metrics above sector average
Key Insights
  • 1. NATHBIOGEN is NOT among the Top 10 largest companies in Other Agricultural Products.
  • 2. The company holds a market share of 1.2% in Other Agricultural Products.
  • 3. In last one year, the company has had an above average growth that other Other Agricultural Products companies.

What does Nath Biogene India Ltd. do?

Other Agricultural Products•Fast Moving Consumer Goods•Small Cap

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win Chi Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Mumbai, India.

Industry Group:Agricultural Food & otherProducts
Employees:423
Website:nathbiogenes.com

Important Disclosure & Data Context

This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.

The Good, Bad and Ugly
Growth
Measures how quickly a company is expanding through metrics like revenue growth, earnings growth, and cash flow growth over time. Strong growth can indicate future potential.
Profitability
Shows how efficiently a company turns business activities into profit, using metrics like profit margins, return on equity (ROE), and return on assets (ROA).
Buy
SMA 20 SignalBuy
SMA 50 SignalSell
SMA 100 SignalSell
Size
Indicates the company's market presence through metrics like market capitalization, total assets, and revenue. Size can influence stability and market influence.
Dilution Rank
Tracks how much the company's shares have increased or decreased over time. Lower dilution means existing shareholders maintain stronger ownership stakes.
Balance Sheet
Evaluates the company's financial health by analyzing assets, debts, and equity. A strong balance sheet indicates financial stability and flexibility.
Momentum
Measures the strength and speed of price movements, showing whether the stock is gaining or losing market favor over different time periods.
Technicals
Analyzes price patterns, trading volumes, and other market indicators to identify potential trading opportunities and market trends.
Smart Money
Tracks the investment activities of institutional investors, hedge funds, and other large financial players who often have deep research capabilities.
Insider Trading
Monitors buying and selling of company shares by executives, directors, and other insiders who may have unique insights into the company's prospects.

Performance Comparison

NATHBIOGEN vs Agricultural (2021 - 2026)

Although NATHBIOGEN is underperforming relative to the broader Agricultural sector, it has achieved a 5.8% year-over-year increase.

Sharesguru Stock Score

NATHBIOGEN

82/100
  1. Question: "What were the main contributors for the 21.3% Y-o-Y growth in gross profit?" Answer: "The main contributors to our gross profit growth were primarily rice and cotton, with maize adding to the total, reflecting strong demand and improved price realizations for these crops."

  2. Question: "With cotton and paddy contributing 74% of revenue, how do you see the mix evolving in the future?" Answer: "We're aiming to achieve a 60-40 balance between Kharif and Rabi crops. However, given the rising demand for cotton and paddy, it may remain approximately 70-30. H2 will see contributions from vegetables and mustard."

  3. Question: "What steps are you taking to improve operational efficiency to enhance your EBITDA margin?" Answer: "The EBITDA margin has compressed primarily due to increased marketing incentives to boost sales, not operational inefficiency. As marketing stabilizes and new products are introduced, we expect to improve margins as customer credits will decrease."

  4. Question: "How do you expect the working capital levels to trend for the rest of FY '26?" Answer: "We anticipate working capital levels to stabilize or increase slightly due to inventory management for Kharif '26. We also expect a reduction in debtors through recoveries and adjustments from advanced bookings, maintaining a manageable level."

  5. Question: "What caused the decline in bajra volumes? And when do you expect improvement?" Answer: "The decline in bajra volumes was marginal, around 5-6%, primarily due to erratic rainfall patterns. With government initiatives focusing on bajra, we expect a significant recovery as conditions improve."

  6. Question: "What are the key strategic priorities for the company in H2 FY '26 and FY '27?" Answer: "Our priorities include continuous product innovation, ensuring quality and farmer satisfaction, timely product placement to reduce returns, and enhancing our product mix to improve profitability while managing operational efficiency across all segments."

  7. Question: "Have you seen any cost increases in the cost of production for cotton?" Answer: "Yes, the cost of production has been rising consistently by about 5-10% annually. We can manage this with margins from other crops beyond cotton, which has its price controlled by the government, limiting our margin expansion."

  8. Question: "How do you view industry's long-term demand fundamentals over the next 2 to 3 years, considering GM might enter into Indian markets?" Answer: "The entry of GM seeds isn't guaranteed, and while permitting GM seeds for cultivation remains a regulatory challenge, we continue to enhance our offerings. Therefore, we remain optimistic about the long-term demand fundamentals based on innovation."

  9. Question: "What guidance can you provide on revenue for the upcoming quarters?" Answer: "We are targeting around 15% growth over the last year. We intend to maintain this target as we move forward, focusing on achieving consistent growth in revenue, backed by operational enhancements and product launches."

  10. Question: "How is the company progressing in Philippines?" Answer: "Currently, our operations in the Philippines are on hold due to delays in government permissions. We are investing time in securing these permissions, but no financial investments are being made at this time."

SEETHA KUMARI2.79%
SATPAL KHATTAR2.1%
PITHAMBAR FARMS PRIVATE LIMITED1.32%
ARATI FARMS PRIVATE LIMITED1.07%
AGRI-TECH (INDIA) LIMITED0%
PROPRIETORY FIRM0%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Income Statement for Nath Biogene India

Consolidated figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Revenue From Operations9.6%365333301---
Revenue From Operations9.6%365333301---
Other Income1059.5%4.550.630.55---
Other Income1059.5%4.550.630.55---
Total Income10.8%369333302---
Total Income10.8%369333302---
Cost of Materials59.6%226142117---
Cost of Materials59.6%226142117---
Purchases of stock-in-trade9.1%13125.31---
Purchases of stock-in-trade9.1%13125.31---
Employee Expense14.8%322823---
Employee Expense14.8%322823---
Finance costs11%109.1110---
Finance costs11%109.1110---
Depreciation and Amortization24.8%3.823.263.01---
Depreciation and Amortization24.8%3.823.263.01---
Other expenses21.7%14712195---
Other expenses21.7%14712195---
Total Expenses11.6%329295266---
Total Expenses11.6%329295266---
Profit Before exceptional items and Tax5.4%403836---
Profit Before exceptional items and Tax5.4%403836---
Exceptional items before tax-118.8%0.543.450---
Exceptional items before tax-118.8%0.543.450---
Total profit before tax-2.4%414236---
Total profit before tax-2.4%414236---
Current tax13%2.041.921.19---
Current tax13%2.041.921.19---
Deferred tax-8.2%-0.050.03-0.03---
Deferred tax-8.2%-0.050.03-0.03---
Total tax3.2%1.981.951.15---
Total tax3.2%1.981.951.15---
Total profit (loss) for period-2.6%394035---
Total profit (loss) for period-2.6%394035---
Other comp. income net of taxes-1800%-0.330.930.02---
Other comp. income net of taxes-1800%-0.330.930.02---
Total Comprehensive Income-7.5%384135---
Total Comprehensive Income-7.5%384135---
Earnings Per Share, Basic-5.9%20.1421.3418.42---
Earnings Per Share, Basic-5.9%20.1421.3418.42---
Earnings Per Share, Diluted-5.9%20.1421.3418.42---
Earnings Per Share, Diluted-5.9%20.1421.3418.42---
Description(%) Q/QDec-2025Sep-2025Jun-2025Dec-2024Sep-2024Jun-2024
Revenue From Operations51.2%66442843732244
Revenue From Operations51.2%66442843732244
Other Income-20.4%1.741.931.760.480.080.13
Other Income-20.4%1.741.931.760.480.080.13
Total Income48.9%68462853732244
Total Income48.9%68462853732244
Cost of Materials400%10622109870.6966
Cost of Materials400%10622109870.6966
Purchases of stock-in-trade102.8%1.020.284.355.213.752.82
Purchases of stock-in-trade
Standalone figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Revenue From Operations8.7%362333301278308280
Revenue From Operations8.7%362333301278308280
Other Income1165.7%4.730.650.551.851.671.82
Other Income1165.7%4.730.650.551.851.671.82
Total Income10.2%367333302280309282
Total Income

Balance Sheet for Nath Biogene India

Consolidated figures (in Rs. Crores) /
Description(%) Q/QSep-2025Mar-2025Sep-2024Mar-2024Sep-2023Mar-2023
Cash and cash equivalents-100.3%0.74892.08771538
Cash and cash equivalents-100.3%0.74892.08771538
Loans, current-5000000
Loans, current-5000000
Total current financial assets12.8%388344341335404306
Total current financial assets12.8%388344341335404306
Inventories-8.9%308338167230163208
Inventories-8.9%308338167230163208
Current tax assets145.7%7.513.655.115.115.656.05
Current tax assets145.7%7.513.655.115.115.656.05
Total current assets2.3%706690516572576521
Total current assets2.3%706690516572576521
Property, plant and equipment0%243243243241234234
Property, plant and equipment0%243243243241234234
Investment property-0006.0500
Investment property-0006.0500
Non-current investments1%5.835.786.058.815.055.05
Non-current investments1%5.835.786.058.815.055.05
Loans, non-current-102.9%0360000
Loans, non-current-102.9%0360000
Total non-current financial assets-56.1%194223205.055.05
Total non-current financial assets-56.1%194223205.055.05
Total non-current assets-8.4%308336313309271272
Total non-current assets-8.4%308336313309271272
Total assets-1.2%1,0141,026828880847793
Total assets-1.2%1,0141,026828880847793
Borrowings, non-current8.3%14132.3100.120.4
Borrowings, non-current8.3%14132.3100.120.4
Total non-current financial liabilities8.3%14132.314.860.120.4
Total non-current financial liabilities8.3%14132.314.860.120.4
Provisions, non-current-1.2%3.513.544.5533.212.79
Provisions, non-current-1.2%3.513.544.5533.212.79
Total non-current liabilities6.2%18176.867.863.343.17
Total non-current liabilities6.2%18176.867.863.343.17
Borrowings, current28.4%141110125105113105
Borrowings, current28.4%141110125105113105
Total current financial liabilities11.2%210189153149131133
Total current financial liabilities11.2%210189153149131133
Provisions, current-113.3%0.680.850.880.880.820.59
Provisions, current-113.3%0.680.850.880.880.820.59
Current tax liabilities213.1%1.690.391.170.950.150.28
Current tax liabilities213.1%1.690.391.170.950.150.28
Total current liabilities-13.2%317365181262239216
Total current liabilities-13.2%317365181262239216
Total liabilities-12.6%334382188270243220
Total liabilities-12.6%334382188270243220
Equity share capital0%191919191919
Equity share capital0%191919191919
Non controlling interest-0000-0.06-
Non controlling interest-0000-0.06-
Total equity5.6%680644640610604573
Total equity5.6%680644640610604573
Total equity and liabilities-1.2%1,0141,026828880847793
Total equity and liabilities-1.2%1,0141,026828880847793
Standalone figures (in Rs. Crores) /
Description(%) Q/QSep-2025Mar-2025Sep-2024Mar-2024Sep-2023Mar-2023
Cash and cash equivalents-100.7%0.35881.39761538
Cash and cash equivalents-100.7%0.35881.39761538
Loans, current-5000000
Loans, current-5000000
Total current financial assets12.3%385343341333404306
Total current financial assets12.3%385343341333404306
Inventories-7.9%305331161229163208
Inventories-7.9%305

Cash Flow for Nath Biogene India

Consolidated figures (in Rs. Crores) /
Finance costs-112.3%
Finance costs-112.3%
Change in inventories-363.4%
Change in inventories-363.4%
Depreciation24.8%
Depreciation24.8%
Net Cashflows from Operations-84.1%
Net Cashflows from Operations-84.1%
Interest paid-
Interest paid-
Interest received-247.7%
Interest received-247.7%
Income taxes paid (refund)112.1%
Income taxes paid (refund)112.1%
Other inflows (outflows) of cash-1328.6%
Other inflows (outflows) of cash-1328.6%
Net Cashflows From Operating Activities-75.4%
Net Cashflows From Operating Activities-75.4%
Proceeds from sales of PPE-
Proceeds from sales of PPE-
Purchase of property, plant and equipment-6.4%
Purchase of property, plant and equipment-6.4%
Purchase of investment property-
Purchase of investment property-
Proceeds from sales of intangible assets22.1%
Proceeds from sales of intangible assets22.1%
Purchase of intangible assets-
Purchase of intangible assets-
Purchase of other long-term assets-
Purchase of other long-term assets-
Interest received480.9%
Interest received480.9%
Net Cashflows From Investing Activities82.5%
Net Cashflows From Investing Activities82.5%
Proceeds from borrowings450.9%
Proceeds from borrowings450.9%
Repayments of borrowings105.2%
Repayments of borrowings105.2%
Dividends paid158.3%
Dividends paid158.3%
Interest paid11%
Interest paid11%
Other inflows (outflows) of cash-5.1%
Other inflows (outflows) of cash-5.1%
Net Cashflows from Financing Activities43.2%
Net Cashflows from Financing Activities43.2%
Net change in cash and cash eq.-73%
Net change in cash and cash eq.-73%
Standalone figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Finance costs-112.3%09.100--
Finance costs-112.3%09.100--
Change in inventories-361.9%-101.64-21.22125.96--
Change in inventories-361.9%-101.64-21.22125.96--
Depreciation23.5%3.793.26-3.013.08--
Depreciation23.5%3.793.26-3.013.08--
Net Cashflows from Operations-80.8%15744810--
Net Cashflows from Operations

Sharesguru Stock Score

NATHBIOGEN

82/100
102.8%
1.02
0.28
4.35
5.21
3.75
2.82
Employee Expense22.2%12109.59108.946.74
Employee Expense22.2%12109.59108.946.74
Finance costs33.1%4.543.663.23.92.982.24
Finance costs33.1%4.543.663.23.92.982.24
Depreciation and Amortization-100%0.980.990.980.820.820.82
Depreciation and Amortization-100%0.980.990.980.820.820.82
Other expenses133.3%2210965.865.9878
Other expenses133.3%2210965.865.9878
Total Expenses63.4%68422503431210
Total Expenses63.4%68422503431210
Profit Before exceptional items and Tax-150.6%-0.213.39363.791.0934
Profit Before exceptional items and Tax-150.6%-0.213.39363.791.0934
Exceptional items before tax59.4%2.692.062.06000
Exceptional items before tax59.4%2.692.062.06000
Total profit before tax-66.8%2.485.46383.791.0934
Total profit before tax-66.8%2.485.46383.791.0934
Current tax63.9%0.870.640.661.050.140.25
Current tax63.9%0.870.640.661.050.140.25
Deferred tax-0000.08-0.160
Deferred tax-0000.08-0.160
Total tax63.9%0.870.640.661.14-0.030.25
Total tax63.9%0.870.640.661.14-0.030.25
Total profit (loss) for period-65.7%1.62.75372.651.1133
Total profit (loss) for period-65.7%1.62.75372.651.1133
Other comp. income net of taxes16.5%0.09-0.09-0.08-0.12-0.11-0.12
Other comp. income net of taxes16.5%0.09-0.09-0.08-0.12-0.11-0.12
Total Comprehensive Income-58.1%1.72.67372.53133
Total Comprehensive Income-58.1%1.72.67372.53133
Earnings Per Share, Basic-140%0.841.419.581.330.5317.49
Earnings Per Share, Basic-140%0.841.419.581.330.5317.49
Earnings Per Share, Diluted-140%0.841.419.581.330.5317.49
Earnings Per Share, Diluted-140%0.841.419.581.330.5317.49
10.2%
367
333
302
280
309
282
Cost of Materials53.9%218142117115149167
Cost of Materials53.9%218142117115149167
Purchases of stock-in-trade20%13115.313.568.967.35
Purchases of stock-in-trade20%13115.313.568.967.35
Employee Expense7.4%302823252419
Employee Expense7.4%302823252419
Finance costs6.8%9.659.110118.826.55
Finance costs6.8%9.659.110118.826.55
Depreciation and Amortization23.5%3.793.263.013.082.821.45
Depreciation and Amortization23.5%3.793.263.013.082.821.45
Other expenses20.8%14612195928180
Other expenses20.8%14612195928180
Total Expenses9.5%323295266255252233
Total Expenses9.5%323295266255252233
Profit Before exceptional items and Tax13.2%443936255749
Profit Before exceptional items and Tax13.2%443936255749
Exceptional items before tax-140.8%03.450-88.7800
Exceptional items before tax-140.8%03.450-88.7800
Total profit before tax4.9%444236-63.395749
Total profit before tax4.9%444236-63.395749
Current tax13%2.041.921.192.3400.16
Current tax13%2.041.921.192.3400.16
Deferred tax-8.2%-0.050.03-0.031.611.09-2.14
Deferred tax-8.2%-0.050.03-0.031.611.09-2.14
Total tax3.2%1.981.951.153.951.09-1.98
Total tax3.2%1.981.951.153.951.09-1.98
Total profit (loss) for period5.1%424035-67.345650
Total profit (loss) for period5.1%424035-67.345650
Other comp. income net of taxes-1800%-0.330.930.0200-0.45
Other comp. income net of taxes-1800%-0.330.930.0200-0.45
Total Comprehensive Income2.5%424135-67.345650
Total Comprehensive Income2.5%424135-67.345650
Earnings Per Share, Basic1.8%2221.6318.42-35.4329.2926.33
Earnings Per Share, Basic1.8%2221.6318.42-35.4329.2926.33
Earnings Per Share, Diluted1.8%2221.6318.42-35.4329.2926.33
Earnings Per Share, Diluted1.8%2221.6318.42-35.4329.2926.33
Description(%) Q/QDec-2025Sep-2025Jun-2025Dec-2024Sep-2024Jun-2024
Revenue From Operations66.7%66402803732244
Revenue From Operations66.7%66402803732244
Other Income-20.4%1.741.931.760.480.070.14
Other Income-20.4%1.741.931.760.480.070.14
Total Income63.4%68422823732244
Total Income63.4%68422823732244
Cost of Materials400%1012110885-0.5263
Cost of Materials400%1012110885-0.5263
Purchases of stock-in-trade102.8%1.020.284.355.213.752.69
Purchases of stock-in-trade102.8%1.020.284.355.213.752.69
Employee Expense15.5%119.669.05108.176.37
Employee Expense15.5%119.669.05108.176.37
Finance costs38.3%4.183.32.893.372.942.24
Finance costs38.3%4.183.32.893.372.942.24
Depreciation and Amortization0%0.980.980.980.820.820.82
Depreciation and Amortization0%0.980.980.980.820.820.82
Other expenses77.8%1710966.62578
Other expenses77.8%1710966.62578
Total Expenses69.4%62372453429210
Total Expenses69.4%62372453429210
Profit Before exceptional items and Tax15.1%5.424.84373.792.8634
Profit Before exceptional items and Tax15.1%5.424.84373.792.8634
Exceptional items before tax-2.6902.06000
Exceptional items before tax-2.6902.06000
Total profit before tax84.9%8.14.84393.792.8634
Total profit before tax84.9%8.14.84393.792.8634
Current tax63.9%0.870.640.661.050.140.25
Current tax63.9%0.870.640.661.050.140.25
Deferred tax-0000.08-0.160
Deferred tax-0000.08-0.160
Total tax63.9%0.870.640.661.14-0.030.25
Total tax63.9%0.870.640.661.14-0.030.25
Total profit (loss) for period94.7%7.234.2382.652.8934
Total profit (loss) for period94.7%7.234.2382.652.8934
Other comp. income net of taxes16.5%0.09-0.09-0.08-0.12-0.11-0.12
Other comp. income net of taxes16.5%0.09-0.09-0.08-0.12-0.11-0.12
Total Comprehensive Income103.2%7.324.11382.542.7834
Total Comprehensive Income103.2%7.324.11382.542.7834
Earnings Per Share, Basic141.4%3.82.1620.061.341.4617.77
Earnings Per Share, Basic141.4%3.82.1620.061.341.4617.77
Earnings Per Share, Diluted141.4%3.82.1620.061.341.4617.77
Earnings Per Share, Diluted141.4%3.82.1620.061.341.4617.77
331
161
229
163
208
Current tax assets0%3.653.655.115.115.656.05
Current tax assets0%3.653.655.115.115.656.05
Total current assets2.5%698681508569576521
Total current assets2.5%698681508569576521
Property, plant and equipment0%243243243241234234
Property, plant and equipment0%243243243241234234
Non-current investments0%6.056.056.066.065.065.05
Non-current investments0%6.056.056.066.065.065.05
Loans, non-current-65.7%133625000
Loans, non-current-65.7%133625000
Total non-current financial assets-56.1%194231175.065.05
Total non-current financial assets-56.1%194231175.065.05
Total non-current assets-8.4%308336320309271272
Total non-current assets-8.4%308336320309271272
Total assets-1.2%1,0051,017829877847793
Total assets-1.2%1,0051,017829877847793
Borrowings, non-current1.6%1.621.612.32.830.120.4
Borrowings, non-current1.6%1.621.612.32.830.120.4
Total non-current financial liabilities1.6%1.621.612.32.830.120.4
Total non-current financial liabilities1.6%1.621.612.32.830.120.4
Provisions, non-current-1.2%3.513.543.4733.212.79
Provisions, non-current-1.2%3.513.543.4733.212.79
Total non-current liabilities-0.7%5.125.155.775.833.343.17
Total non-current liabilities-0.7%5.125.155.775.833.343.17
Borrowings, current28.4%141110125105113105
Borrowings, current28.4%141110125105113105
Total current financial liabilities65.8%311188152148238133
Total current financial liabilities65.8%311188152148238133
Provisions, current560%1.690.850.880.8800.59
Provisions, current560%1.690.850.880.8800.59
Current tax liabilities-63.9%00.391.170.950.150.28
Current tax liabilities-63.9%00.391.170.950.150.28
Total current liabilities-13.8%313363180261239216
Total current liabilities-13.8%313363180261239216
Total liabilities-13.6%318368185266242220
Total liabilities-13.6%318368185266242220
Equity share capital0%191919191919
Equity share capital0%191919191919
Total equity5.9%687649643611605573
Total equity5.9%687649643611605573
Total equity and liabilities-1.2%1,0051,017829877847793
Total equity and liabilities-1.2%1,0051,017829877847793
-80.8%
15
74
48
10
-
-
Interest paid--9.65010-10.61--
Interest paid--9.65010-10.61--
Interest received296.2%3.59-0.320.02-1.09--
Interest received296.2%3.59-0.320.02-1.09--
Income taxes paid (refund)112.1%1.080.34-0.922.88--
Income taxes paid (refund)112.1%1.080.34-0.922.88--
Other inflows (outflows) of cash-1328.6%00.9300--
Other inflows (outflows) of cash-1328.6%00.9300--
Net Cashflows From Operating Activities-64.9%27753817--
Net Cashflows From Operating Activities-64.9%27753817--
Proceeds from sales of PPE6.3%0.110.050.050.07--
Proceeds from sales of PPE6.3%0.110.050.050.07--
Purchase of property, plant and equipment-74%7.75272.481.1--
Purchase of property, plant and equipment-74%7.75272.481.1--
Purchase of investment property--0.01100.01--
Purchase of investment property--0.01100.01--
Purchase of intangible assets-000.070.02--
Purchase of intangible assets-000.070.02--
Purchase of other long-term assets-000.420--
Purchase of other long-term assets-000.420--
Interest received480.9%3.590.320.021.09--
Interest received480.9%3.590.320.021.09--
Net Cashflows From Investing Activities82.2%-4.05-27.4-2.88-19.87--
Net Cashflows From Investing Activities82.2%-4.05-27.4-2.88-19.87--
Proceeds from borrowings116.9%4.082.42-0.260.01--
Proceeds from borrowings116.9%4.082.42-0.260.01--
Repayments of borrowings-90%1.223.21-13.37-2.43--
Repayments of borrowings-90%1.223.21-13.37-2.43--
Dividends paid0%3.83.83.83.8--
Dividends paid0%3.83.83.83.8--
Interest paid6.8%9.659.11011--
Interest paid6.8%9.659.11011--
Other inflows (outflows) of cash-135.8%-0.033.88-0.85-10.26--
Other inflows (outflows) of cash-135.8%-0.033.88-0.85-10.26--
Net Cashflows from Financing Activities-7.5%-10.62-9.81-1.67-22.23--
Net Cashflows from Financing Activities-7.5%-10.62-9.81-1.67-22.23--
Net change in cash and cash eq.-70.3%123834-25.05--
Net change in cash and cash eq.-70.3%123834-25.05--